Whilding and colleagues came to a similar conclusion that CXCR2-expressing CAR-T cells efficiently migrated towards tumor-conditioned media containing IL-8 and had a more favorable toxicity profile of eliciting anti-cancer responses against αvβ6-expressing ovarian or pancreatic tumor xenografts 149. Here, CXCR2 is linked to cancer.